C12N 2710/10143
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2710/10143 (Viral genome or elements thereof as genetic vector) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 8
- Assignees
- 7
- Inventors
- 26
- Latest grant
- 28 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Formulation28 Feb 2023US 11,590,243 B2Glaxosmithkline Biologicals SA
- Replicating recombinant adenovirus vectors, compositions, and methods of use thereof5 Sep 2017US 9,750,801 B2Beth Israel Deaconess Medical Center, Inc.
- DNA encoding ovine adenovirus (OAV287) and its use as a viral vector2 May 2006US 7,037,712 B2Commonwealth Scientific and Industrial Research Organisation
- Cell line preparing and producing ovine adenovirus vectors23 Nov 2004US 6,821,777 B2Develogen Aktiengesellschaft fur Entwicklungsbiologische Forschung
- Adenovirus delivery system for cancer treatment16 Jan 2025US 2025/0018060 A1Christiana Care Gene Editing Institute, Inc.
- Novel formulation5 Dec 2019US 2019/0365930 A1Glaxosmithkline Biologicals SA
- Replicating recombinant adenovirus vectors, compositions, and methods of use thereof3 Sep 2015US 2015/0246112 A1Beth Israel Deaconess Medical Center, Inc.
- Vaccination regimen21 Jul 2011US 2011/0177115 A1
- Composition and method for killing of tumours23 Apr 2009US 2009/0104154 A1Commonwealth Scientific and Industrial Research Organisation
Most cited
By later US patents
- DNA encoding ovine adenovirus (OAV287) and its use as a viral vector21US 7,037,712 B2Commonwealth Scientific and Industrial Research Organisation · 2006
- Replicating recombinant adenovirus vectors, compositions, and methods of use thereof9US 9,750,801 B2Beth Israel Deaconess Medical Center, Inc. · 2017